In Bill Gates Year in Review of 2020, he ponders a
Post# of 148168
"Another approach to treatment you may have read about is called monoclonal antibodies.
Scientists also need to see if it’s possible to replace the current IV infusion with a two-shot dose.
If researchers solve the dosage and infusion challenges, then the main limiting factor will be manufacturing capacity."
https://www.gatesnotes.com/About-Bill-Gates/Y...eview-2020